Irinotecan

Concentrate for solution for infusion

For GB healthcare professionals only.
 
Irinotecan is available as a 20mg/ml concentrate for solution for infusion.

Scroll down for ordering codes and pack size information. 

For further information on this product, you can find the Summary of Product Characteristics (SmPC) using the MHRA products website. By clicking the link, you will leave the Fresenius Kabi UK website and be directed to the MHRA products website.

https://products.mhra.gov.uk/

Details

Item descriptionPackaging  Case qtyItem code
Irinotecan 40mg/2ml concentrate for solution for infusion2ml vial19480002830
Irinotecan 100mg/5ml concentrate for solution for infusion5ml vial 19480002831
Irinotecan 300mg/15ml concentrate for solution for infusion15ml vial19480002832
Irinotecan 500mg/25ml concentrate for solution for infusion25ml vial19480002833

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk  Adverse events should also be reported to Fresenius Kabi Limited.  Email: Pharmacovigilance.GB@fresenius-kabi.com

GB-Onco-2400003 December 2024